Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

721 articles

Research Review

Showing 1–1 of 1 articles · Keyword: ligand-modified lipid nanoparticles Clear keyword

AAPS PharmSciTech2026ReviewDrug Delivery

1. Ligand-modified Lipid-based Drug Delivery Vehicles for the Selective Targeting of Cancerous Cells

Eknure C, Kumar M, Bachhav Y

Chemotherapy is widely recognized as the mainstay of cancer therapy; however, its lack of specificity and off-target toxicities limit therapeutic success. The lipid-based nanocarriers with targeting ligands such as folic acid, transferrin, aptamers, and antibodies are widely recognized as effective for cancer cell…

Read the article

Let's engineer the next delivery breakthrough together

We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.

ResearchersRequest a technical consultationTalk formulation, characterisation or assay design with one of our scientists.Industry partnersExplore co-developmentFeasibility studies, co-development programmes and licensing.InvestorsExplore the market opportunitySourced market sizes, pipeline, investment and deal data for genetic medicine delivery.